Dongfeng Han

975 total citations
28 papers, 754 citations indexed

About

Dongfeng Han is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Dongfeng Han has authored 28 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Dongfeng Han's work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Dongfeng Han is often cited by papers focused on RNA modifications and cancer (6 papers), MicroRNA in disease regulation (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Dongfeng Han collaborates with scholars based in China and United States. Dongfeng Han's co-authors include Tianfu Yu, Yingyi Wang, Wenjin Wei, Yongping You, Qi Hu, Junxia Zhang, Sisi Wang, Ning Liu, Bo Wang and Nan Dong and has published in prestigious journals such as IEEE Transactions on Medical Imaging, Medicine and BioMed Research International.

In The Last Decade

Dongfeng Han

28 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongfeng Han China 18 404 219 101 92 77 28 754
Peng Peng China 13 150 0.4× 85 0.4× 164 1.6× 128 1.4× 100 1.3× 43 702
Yu Yan China 10 252 0.6× 118 0.5× 44 0.4× 53 0.6× 57 0.7× 30 543
Reid T. Powell United States 12 604 1.5× 174 0.8× 157 1.6× 56 0.6× 21 0.3× 38 949
Xiaoying Liu United States 17 208 0.5× 171 0.8× 234 2.3× 109 1.2× 216 2.8× 77 821
Xiao‐Yue Zhai China 14 357 0.9× 106 0.5× 41 0.4× 33 0.4× 51 0.7× 31 711
Yijun Cheng China 18 413 1.0× 150 0.7× 129 1.3× 29 0.3× 48 0.6× 52 1.2k
Zhihao Wu China 12 475 1.2× 328 1.5× 199 2.0× 31 0.3× 29 0.4× 34 940
Min Hou China 15 203 0.5× 109 0.5× 166 1.6× 126 1.4× 42 0.5× 45 924
Luting Zhou China 14 304 0.8× 152 0.7× 72 0.7× 20 0.2× 87 1.1× 49 589

Countries citing papers authored by Dongfeng Han

Since Specialization
Citations

This map shows the geographic impact of Dongfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongfeng Han more than expected).

Fields of papers citing papers by Dongfeng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongfeng Han. The network helps show where Dongfeng Han may publish in the future.

Co-authorship network of co-authors of Dongfeng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Dongfeng Han. A scholar is included among the top collaborators of Dongfeng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongfeng Han. Dongfeng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Wanli, et al.. (2022). Circ-FAT1 Up-Regulates FOSL2 Expression by Sponging miR-619-5p to Facilitate Colorectal Cancer Progression. Biochemical Genetics. 60(4). 1362–1379. 10 indexed citations
2.
Han, Dongfeng, et al.. (2021). Can kissing cause paraquat poisoning: A case report and review of literature. World Journal of Clinical Cases. 9(20). 5588–5593. 3 indexed citations
3.
Wu, Jing, et al.. (2021). Identification of key genes as predictive biomarkers for osteosarcoma metastasis using translational bioinformatics. Cancer Cell International. 21(1). 640–640. 11 indexed citations
4.
Han, Dongfeng, et al.. (2020). An Update on the Emerging Role of Visfatin in the Pathogenesis of Osteoarthritis and Pharmacological Intervention. Evidence-based Complementary and Alternative Medicine. 2020(1). 8303570–8303570. 11 indexed citations
5.
Jiang, Xiaoming, et al.. (2020). Protective Effects and Mechanisms of Action of Ulinastatin against Cerebral Ischemia-Reperfusion Injury. Current Pharmaceutical Design. 26(27). 3332–3340. 32 indexed citations
7.
Han, Dongfeng, Tianfu Yu, Nan Dong, et al.. (2019). Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells. Journal of Experimental & Clinical Cancer Research. 38(1). 289–289. 73 indexed citations
8.
Wang, Sisi, et al.. (2019). LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression. Artificial Cells Nanomedicine and Biotechnology. 47(1). 1342–1348. 38 indexed citations
9.
Zhong, Wei, et al.. (2019). Elevated frequencies of total and MAIT cell subsets in patients with knee osteoarthritis. PeerJ. 7. e7443–e7443. 2 indexed citations
10.
Xing, Jihong, et al.. (2019). CREB Protects against Temporal Lobe Epilepsy Associated with Cognitive Impairment by Controlling Oxidative Neuronal Damage. Neurodegenerative Diseases. 19(5-6). 225–237. 28 indexed citations
11.
Liu, Yijun, et al.. (2019). A Mini Review: Stem Cell Therapy for Osteonecrosis of the Femoral Head and Pharmacological Aspects. Current Pharmaceutical Design. 25(10). 1099–1104. 7 indexed citations
12.
Sun, Fei, et al.. (2015). Caffeine-induced nuclear translocation of FoxO1 triggers Bim-mediated apoptosis in human glioblastoma cells. Tumor Biology. 37(3). 3417–3423. 17 indexed citations
13.
Han, Dongfeng, Junxia Zhang, Wenjin Wei, et al.. (2015). Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27kip pathway in human glioblastoma cells. Tumor Biology. 36(5). 3823–3829. 32 indexed citations
14.
Zhang, Yaxuan, Dongfeng Han, Wenjin Wei, et al.. (2015). MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2. Cellular and Molecular Neurobiology. 35(8). 1165–1173. 26 indexed citations
15.
Han, Dongfeng, Wenjin Wei, Xincheng Chen, et al.. (2015). NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells. Oncotarget. 6(28). 26119–26128. 45 indexed citations
16.
Wei, Wenjin, Xiupeng Xu, Hailin Li, et al.. (2014). The SIRT2 Polymorphism rs10410544 and Risk of Alzheimer’s Disease: A Meta-analysis. NeuroMolecular Medicine. 16(2). 448–456. 23 indexed citations
17.
Tao, Tao, Chunhui Liu, Dongfeng Han, et al.. (2014). Loss of SNAIL inhibits cellular growth and metabolism through the miR-128-mediated RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells. Tumor Biology. 35(9). 8543–8550. 26 indexed citations
18.
Tao, Tao, Yan Shi, Dongfeng Han, et al.. (2014). TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas. Tumor Biology. 35(9). 9053–9059. 23 indexed citations
19.
Song, Qi, Dongfeng Han, Wenqing Sun, et al.. (2013). Optimal Co-Segmentation of Tumor in PET-CT Images With Context Information. IEEE Transactions on Medical Imaging. 32(9). 1685–1697. 103 indexed citations
20.
Han, Dongfeng, Xiaodong Wu, & Milan Sonka. (2009). Optimal multiple surfaces searching for video/image resizing - a graph-theoretic approach. 1026–1033. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026